Cardiotonic agents. 2. Synthesis and structure-activity relationships of 4,5-dihydro-6-[4-(H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones: a new class of positive inotropic agents
Citations Over TimeTop 10% of 1985 papers
Abstract
A series of 4,5-dihydro-6-[4-(1H-imidazol-1-yl)phenyl]-3(2H)-pyridazinones and related compounds were synthesized and evaluated for positive inotropic activity. Most members of this series produced dose-related increases in myocardial contractility that were associated with relatively minor increases in heart rate and decreases in systemic arterial blood pressure. Introduction of a methyl substituent at the 5-position of 1 (CI-914) produced the most potent compound in this series (11, CI-930). Compound 1 is more potent than amrinone whereas compound 11 is more potent than milrinone. The inotropic effects of 1 and 11 are not mediated via stimulation of beta-adrenergic receptors. Selective inhibition of cardiac phosphodiesterase fraction III represents the principal component of the positive inotropic action of 1 and 11.
Related Papers
- → A Multicenter, Randomized, Blind Comparison of Amrinone with Milrinone After Elective Cardiac Surgery(1998)51 cited
- → Positive Inotropic and Vasodilating Effects of Amrinone and Milrinone in Isolated Canine Heart(1987)16 cited
- → Arrhythmogenic potencies of amrinone and milrinone in unanesthetized dogs with myocardial infarct(1992)6 cited
- → Role of adenosine antagonism and phosphodiesterase inhibition in the inotropic and chronotropic actions of amrinone, milrinone and milrinone analogues(1992)1 cited
- Reduction of 4-epiadriamycin cardiotoxicity by milrinone, a new cardiotonic agent.(1989)